Albany, NY -- (SBWIRE) -- 01/19/2017 -- Global Cell Based Assays Market: Overview

Cell biology and information on the underlying molecular processes is essential for the treatment of several diseases and development of new drugs. While most of our current knowledge about cell biology has evolved using biochemical assays, cell based assays are primed to revolutionize the way cellular mechanism is studied in biological context. The term "cell based assay" implicates the use of live cells to gather information on the effect of a foreign substance on the behavior and functionality of a cell. Presently, cell based assays are the most accurate method available for cell testing, which are used to determine factors such as cell proliferation, cell toxicity, cell morphology, and motility.

Cell based assay can range from cytotoxic assays, which includes apoptosis, to metabolic assays and cell proliferation. The development of cell based assay also includes high throughput screening assays, which are used to characterize drug stability for GLP GMP lot release. It also helps in checking drug potency and for drug purification, as well as production support. Mechanisms of action, such as receptor activation, receptor binding, cell signaling, subcellular localization, and drug internalization can be delineated in cell-based assays following treatment via pharmaceuticals.

Download exclusive Sample of this report: https://goo.gl/TfCEC2

Cell based assays are utilized by pharmaceutical companies, biotechnology companies, academic research institutes, contract research organizations, government institutes, and others. Apart from numerous possibilities in future, cell based assays are already proving their usefulness in research of life-threatening diseases such as cancer and immunology. Concurrently, the global market for cell based assays is projected for a robust growth rate during the forecast period of 2016–2024.

Global Cell Based Assays Market: Trends and Opportunities

The emergence of new technologies and revolutionary branches of science and medicine are significantly boosting the uptake of cell based assays. It has also been noted that the global market for cell based assays is feeding off rising expenditure on research and development and increased usage of cell based assays in drug discovery because of several benefits offered by this method. For instance, Symcel, the company behind calScreener, which is a cell based assay tool for real-time cellular bioenergetic measurements, has collaborated with Colzyx to test 25 different new collagen VI derived antimicrobial peptides. These newly discovered and first-in-kind peptides may be able to kill bacterial growth in different ways. The cell based assay technology will also be used to test each peptide independently, or in combination with others.

Some of the other factors driving the global cell based assay market are: increased investments by pharmaceutical companies in drug discovery, the increasing adoption rate of cell assay based high throughput screening methods of drug compound screening, and replacement of in vivo toxicity testing by in vitro testing methods. Emergence of new branches in bio-science such as synthetic biology, which depends on accurate cell testing, is another factor that will ensure a healthy future growth of the cell based assay market.

View exclusive Global strategic Business report:
http://www.transparencymarketresearch.com/cell-based-assays.html

Global Cell Based Assays Market: Region-wise Outlook

Geographically, the global cell based assays are segmented into North America, Europe, Asia Pacific, and Rest of the World. Over the past few years, North America has presented the strongest market for cell based assays due to the presence of major pharmaceutical companies in The U.S. and Canada. These two countries are financially equipped, and are dedicated toward drug-based research and development. The market in this region is also supported by the growing presence of advanced biotechnology laboratories.

On the other hand, vastly populated region of Asia Pacific is expected to develop into a lucrative market for cell-based assays towards the end of the forecast period, with countries such as India and China inviting most of the demand. Extended demand from Asia Pacific is also attributed to low labor cost in this region, which has lured several pharmaceutical companies to set up shop and make the most of the conducive environment.

Companies mentioned in the research report

Some of the prominent players in the global cell based assays market are GE Healthcare Life Sciences, PerkinElmer Inc., Cisbio Bioassays, BioVision Inc., Sigma-Aldrich, DiscoveRx Corp., Caliper Life Sciences Inc., Promega Corporation, ProQinase GmbH, Thermo Fisher Scientific Inc., EMD Millipore, Life Technologies, Beckman Coulter Inc., Xenometrix AG, and D Biosciences.